Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study. Garcia-Grimshaw M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al. Vaccine 2021 Oct 29. pii: S0264-410X(21)01391.

Read + Share

Amedeo Smart

Independent Medical Education

Garcia-Grimshaw M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al. Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study. Vaccine 2021 Oct 29. pii: S0264-410X(21)01391.
PMID: 34742595